AJMC June 19, 2025
Mary Caffrey

Key Takeaways

  • Value-based care in oncology emphasizes access, outcomes, and affordability, with patient empowerment and clinical trials being crucial components.
  • CAR T-cell and bispecific therapies have revolutionized treatment, but financial toxicity and accessibility challenges persist.
  • Pharmacists are integral in managing adverse events, ensuring treatment accessibility, and expediting insurance approvals.
  • Collaborations and innovative care models are essential for balancing innovation with affordability and improving patient quality of life.

Coverage from IVBM Princeton, held May 8, 2025.

The last time The American Journal of Managed Care (AJMC) hosted a meeting in Princeton, New Jersey, was 2014, as millions of Americans were gaining health coverage under the Affordable Care Act—some for the first time in their lives.

Across health care, people...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Patient / Consumer, Payment Models, Pharma, Pharma / Biotech, Provider, Value Based
Reengineering ACOs To Make Medicare Competitive
Follow the money: How AI technology could fit into accountable care
Are Hospitals Procrastinating on TEAM Model Work?
The AI leadership gap threatening value-based care
Generative AI in Value-Based Care and Risk-Bearing Organizations

Share Article